2m 2m 2m 2m 2m 2m 2m
Edwards Lifescns (EW)
NYSE
$86.96+$1.08 (+1.26%)
Price as of Jun 23, 2026 5:52 PM EDT- $49.4BMarket Cap
- 14.02%1-Year Change
- Medical DevicesIndustry
Edwards Lifescns (EW)
$86.96+$1.08 (+1.26%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.1B +11.55% | 5.4B -9.41% | 6.0B +11.56% | 5.4B +2.86% | |
Cost of Revenue | 1.3B +19.39% | 1.1B -19.01% | 1.4B +27.71% | 1.1B -13.49% | |
Gross Profit | 4.7B +9.52% | 4.3B -6.55% | 4.6B +7.51% | 4.3B +7.99% | |
Sales and Marketing Expense | 2.1B +16.54% | 1.8B -1.94% | 1.8B +16.39% | 1.6B +4.95% | |
Research and Development Expense | -1.1B +2.49% | -1.1B -1.75% | -1.1B +13.39% | -945.2M +4.66% | |
Depreciation and Amortization Expense | 156.6M +0.90% | 155.2M +7.11% | 144.9M +3.80% | 139.6M +3.56% | |
Total Operating Expenses | 1.3B +19.39% | 1.1B -19.01% | 1.4B +27.71% | 1.1B -13.49% | |
Operating Profit | 1.3B -8.30% | 1.4B -10.13% | 1.5B -12.26% | 1.7B +3.44% | |
Interest Income | 168.8M +40.32% | 120.3M +79.02% | 67.2M +89.30% | 35.5M +104.02% | |
Interest Expense | -20.4M +3.03% | -19.8M +12.50% | -17.6M -8.33% | -19.2M +4.35% | |
Interest Income and Expense and Net | 148.4M +47.66% | 100.5M +102.62% | 49.6M +204.29% | 16.3M +1,730.00% | |
Total Nonoperating Income and Expense | 7.2M -89.55% | 68.9M +378.47% | 14.4M +453.85% | 2.6M -79.53% | |
Income before Taxes | 1.3B -17.78% | 1.5B -3.13% | 1.6B -9.58% | 1.8B +3.84% | |
Income Taxes | 216.9M +42.60% | 152.1M -23.45% | 198.7M -19.06% | 245.5M +23.43% | |
Extraordinary Items | 186.9M N/A | 0 N/A | 0 -100.00% | 55.1M N/A | |
Net Income | 1.1B -74.28% | 4.2B +197.68% | 1.4B -7.85% | 1.5B +1.25% | |
Net Income from Continuing Operations Applicable to Common | 1.3B -17.78% | 1.5B -3.13% | 1.6B +5.01% | 1.5B +1.25% | |
Basic EPS and Net Income | 1.84 -73.64% | 6.98 +202.16% | 2.31 -6.10% | 2.46 +2.07% | |
Diluted EPS and Net Income | 1.83 -73.74% | 6.97 +203.04% | 2.30 -5.74% | 2.44 +2.52% | |
Basic Weighted Average Shares | 584.8M -2.16% | 597.7M -1.48% | 606.7M -1.99% | 619.0M -0.69% | |
Diluted Weighted Average Shares | 585.8M -2.25% | 599.3M -1.66% | 609.4M -2.37% | 624.2M -1.11% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.9B -3.52% | 3.0B +166.19% | 1.1B +48.76% | 769.0M -10.87% | |
Short-Term Investments | 1.3B +38.42% | 930.7M +85.95% | 500.5M +12.14% | 446.3M -26.11% | |
Cash and Cash Equivalents and Short-Term Investments | 4.2B +6.30% | 4.0B +141.77% | 1.6B +35.32% | 1.2B -17.15% | |
Total Current Assets | 6.7B +7.22% | 6.3B +55.74% | 4.0B +30.36% | 3.1B -2.67% | |
Accumulated Depreciation | 849.8M +6.96% | 794.5M -7.34% | 857.4M +14.26% | 750.4M +14.63% | |
Property and Plant and Equipment and Net | 1.8B +7.47% | 1.7B -3.62% | 1.7B +7.14% | 1.6B +5.57% | |
Total Long-Term Assets | 730.2M +1.19% | 721.6M +55.62% | 463.7M +55.03% | 299.1M +169.95% | |
Total Assets | 13.7B +4.92% | 13.1B +39.43% | 9.4B +12.91% | 8.3B -2.47% | |
Income Taxes Payable | 192.5M +14,707.69% | 1.3M -98.39% | 80.6M -43.79% | 143.4M -24.53% | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 1.8B +20.50% | 1.5B +25.92% | 1.2B +16.92% | 1.0B -0.96% | |
Total Long-Term Debt | 598.3M +0.10% | 597.7M +0.12% | 597.0M +0.12% | 596.3M +0.10% | |
Total Long-Term Liabilities | 362.3M +1.34% | 357.5M +35.26% | 264.3M +21.52% | 217.5M -18.63% | |
Total Liabilities | 3.4B +12.27% | 3.0B +13.19% | 2.6B +6.36% | 2.5B -6.78% | |
Retained Earnings | 14.2B +8.15% | 13.2B +46.42% | 9.0B +18.48% | 7.6B +25.08% | |
Total Stockholders Equity | 10.3B +3.39% | 10.0B +50.35% | 6.7B +14.52% | 5.8B -0.50% | |
Total Shares Outstanding | 580.7M -1.34% | 588.6M -2.08% | 601.1M -1.18% | 608.3M -2.53% | |
Cash Flow | |||||
Cash from Operating Activities | 1.6B +194.15% | 542.3M -39.46% | 895.8M -26.47% | 1.2B -29.67% | |
Capital Expenditures | 260.2M +3.09% | 252.4M -0.24% | 253.0M +3.43% | 244.6M -24.92% | |
Cash from Investing Activities | -712.9M -130.82% | 2.3B +1,230.78% | 173.8M -31.11% | 252.3M +114.65% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -956.8M -2.67% | -983.0M +38.26% | -711.0M -55.13% | -1.6B +344.71% | |
Financials Ratio | |||||
Gross Margin | 78.01% -1.82% | 79.46% +3.16% | 77.02% -3.64% | 79.93% +4.99% | |
Operating Margin | 20.84% -17.80% | 25.35% -0.79% | 25.55% -21.36% | 32.49% +0.56% | |
Return on Assets | 8.03% -78.45% | 37.24% +134.43% | 15.89% -12.34% | 18.12% -5.11% | |
Return on Equity | 10.56% -78.95% | 50.15% +122.73% | 22.52% -13.87% | 26.14% -9.47% | |
Revenue Growth | 11.55% +222.66% | -9.41% -181.41% | 11.56% +303.64% | 2.86% -85.15% | |
Current Ratio | 3.72 -11.02% | 4.18 +23.69% | 3.38 +11.49% | 3.03 -1.73% | |
Cash Ratio | 1.62 -19.93% | 2.02 +111.40% | 0.96 +27.23% | 0.75 -10.00% | |
Debt-to-Equity Ratio | 0.06 -3.18% | 0.06 -33.41% | 0.09 -12.56% | 0.10 +0.59% | |
Debt-to-Assets Ratio | 0.04 -4.59% | 0.05 -28.21% | 0.06 -11.27% | 0.07 +2.57% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow